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CLINICAL CASE SEMINAR
An Unusual Pituitary Pathology
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NONADENOMATOUS lesions of the pituitary repre-sent a small part of the intrasellar processes. How-
ever, when encountered, they may present a diagnostic dif-
ficulty (1).
Most of them are discovered because of the tumoral syn-
drome, due to the compression of the pituitary and the sur-
rounding structures, and may lead to hypopituitarism, dia-
betes insipidus, secondary hyperprolactinemia, visual field
disturbances, and oculomotor abnormalities. None of these
signs are fairly specific of these lesions, and, with the ex-
ception of diabetes insipidus which is more rare, they could
very often be seen in pituitary adenomas. In some cases
however, these tumors may be incidentalomas, provoking no
pituitary or ocular dysfunction.
Making a more precise diagnosis on the basis of biological,
hormonal, and radiological examinations is of primary im-
portance, as it may lead to a less aggressive, although very
efficient, medical therapy in some cases.
The case history we are presenting here shows the diffi-
culties encountered in the diagnosis of these unusual pitu-
itary processes and highlights the potential interest of re-
cently developed techniques in the endocrinological
exploration of these patients.
Case Report
A 54-yr-old menopausal woman of Caucasian origin was
admitted to the hospital complaining of extreme weakness,
headache, and vomiting. The patient had no previous med-
ical history and was taking no medication. At clinical exam-
ination, she presented with signs of hypopituitarism and a
mild diabetes insipidus. The basic laboratory tests showed an
inflammatory syndrome, with a rise of sedimentation rate to
81 mm/h, fibrinogen to 8 g/L, but normal white blood cell
count. Endocrine tests at admission showed a complete an-
terior pituitary deficiency, with undetectable gonadotropin
and TSH values for a low estradiol and free T3-T4, low
insulin-like growth factor I, and no stimulation of GH and
cortisol by insulin tolerance test.
Pituitary computed tomography scan and magnetic res-
onance imaging (MRI) examinations were performed (Fig. 1),
showing an endosellar mass and a thickening of the pituitary
stalk. There were no intrasellar calcifications. The clinical
history and the radiological imaging were not in favor of a
pituitary adenoma. Diabetes insipidus is rare even in non-
functionning adenomas. Moreover, a pituitary stalk involve-
ment by an intrasellar adenoma is very rare.
These examinations suggested that this lesion belongs
probably to other types of sellar lesions, which are listed in
Table 1.
Because of the nonavailability of gadolinium at that time,
contrast images were not performed. However, the T1 and T2
weighted images were not in favor of a cystic lesion nor of
a craniopharyngioma. Other diagnoses like intrasellar he-
matoma, melanoma, lipoma, vascular (2) or bony tumor were
unlikely because of the lack of the MRI signal modifications
usually found in these lesions. Moreover, the very high sed-
imentation rate could not be explained by these lesions. An
inflammatory lesion or a secondary tumor were therefore
considered, and a general screening was started to better
determine the diagnosis.
Pituitary abscesses (3) usually appear in a context of sep-
ticemia, which was not found in our patient. These could be
associated with a purulent central nervous system fluid and,
in some cases, a rise in white blood cells, none of which were
present.
Tuberculosis skin test was negative, and body fluid
cultures for bacteria and mycobacteria were sterile. More-
over, radiological examinations did not show any primary
tuberculous lesion. Syphilitic serology (VDRL and TPHA)
was negative. All autoimmunity markers, including an-
tineotrophil cytoplasmic antibodies, were normal. Screen-
ing for a primary neoplasia, including chest X-ray and
computed tomography, gastroscopy, abdominal echoto-
mography, gynecological examination, and mammogra-
phy, did not unveil any tumorous lesion. For all these
reasons, an abscess, or a tuberculous (4, 5), syphylitic, or
metastatic (6) lesion seemed to be unlikely.
A pituitary localization of a lymphoma or a plasmocytoma
was very unlikely, as this sole localization has rarely been
described (7).
The clinical history and the age of the patient were not in
favor of a lymphocytic hypophysitis (8, 9), which usually
occurs after a pregnancy and presents a less dramatic
occurrence.
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Langerhans-cell histiocytosis usually shows the involve-
ment of other organs and does not cause a rise in sedimen-
tation rate (10). However a unique pituitary localization is
possible, and the definite diagnosis may only be given by a
biopsy of the lesion (11). Granular cell tumors are usually
asymptomatic (12). Neurosarcoidosis is a rare diagnosis (5%
of all sarcoidosis cases), but a possible diagnosis for our case
(13, 14). Laboratory tests showed, however, normal angio-
tensin-converting enzyme values that, without excluding
this disease, gave another argument against it. Wegener’s
granulomatosis (15, 16) was possible too, despite the lack of
involvement of other organs and the presence of normal
ANCAs. Because of the lack of definite arguments, an in-
flammatory pituitary granuloma was considered the most
likely diagnosis.
The patient was treated by hormonal replacement therapy
(0.1 mg tyroxine and 25 mg hydrocortisone daily). She was
then discharged from the hospital and referred to our insti-
tution to discuss the indications for a pituitary biopsy. She
was retested for infectious and autoimmunity markers. The
results were similar to those previously obtained. The screen-
ing for a primary tumor was continued by an examination of
the upper respiratory tract. A granulomatous lesion of the
cavum was found and biopsied.
First histological examination
Histological examination of the cavum biopsy showed an
ill-defined granulomatous inflammation with the presence
of epithelioid cells, giant plurinucleated cells, and small areas
of nonspecific necrosis. On the basis of histology alone, a
diagnosis of either Wegener’s granulomatosis or tuberculosis
was first proposed.
Several special stains were then performed. The orcein
staining demonstrated some vascular modifications in
medium-sized arteries that may accompany Wegener’s gran-
ulomatosis. No organisms were seen on Zielh-Neelsen stains
FIG. 1. A and B: Pituitary magnetic resonance imaging at time of admission, showing an intrasellar mass and a thickening of the pituitary
stalk.
TABLE 1. Some of the nonadenomatous pituitary tumors already described in the literature (1)
Noninflammatory tumors Inflammatory tumors Cysts Others
Granulous cell Abscess Rathke Hamartomas
Craniopharyngioma Sarcoidosis Arachnoid Gangliocytomas
Chordoma Lymphocytic hypophysitis Epidermoid Accessory salivary glands
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of the tissue. On the basis of these results, the diagnosis of
Wegener’s granulomatosis was preferred.
Clinical course
The patient was therefore treated with corticosteroids
(prednisolone). She was then lost for follow-up. Two months
later she again presented to the hospital. She was still under
corticosteroids and complained of the reappearance of head-
ache and vomiting. Clinical examination showed the pres-
ence of cavernous and chiasmatic syndromes. At MRI ex-
amination, the lesion showed an increase in size with a
suprasellar extension, a chiasmatic compression, and a lat-
eral extension in the cavernous sinuses (Fig. 2). Contrast
images showed a peripheral shell with a necrotic center.
There was no meningial involvement.
The patient underwent a pituitary surgery by a transsphe-
noidal approach. The neurosurgeon (A.S.) proceeded to a
large debulking of the tumor, relieving the chiasmatic com-
pression. Tissue samples were sent to the pathology
department.
Second histological examination
The histological aspect was quite similar to that described
for the cavum. At low magnification, the normal pituitary
FIG. 2. A, B, C: Pituitary magnetic resonance imaging, showing A, an increase in size of the intrasellar mass; B, a suprasellar extension; and
C, a peripheral shell after contrast.
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tissue was replaced by an extensive inflammation. At higher
magnification, granulomatous features were observed with
the presence of epithelioid cells and giant plurinucleated
cells (Fig. 3). Focal areas of necrosis were also present but did
not exhibit the typical aspect of caseation. As in the previous
sample, no acid-fast bacilli were detected by the Zhiel stain-
ing. A diagnosis of granulomatous hypophysitis was pro-
posed and probably related, because of the history of the
patient, to a Wegener’s granulomatosis.
Clinical course
On the basis of clinical suspicion, the worsening of the
symptoms under corticoids, and the fact that pathological
examination could not exclude an infectious etiology, the
patient was empirically treated by antituberculosis trith-
erapy. Three months after the beginning of this treatment,
there were a tremendous improvement in the clinical con-
ditions and a complete disappearance of the inflammatory
syndrome. To definitely determine wheter the patient had a
mycobacterial infection, a detection of Mycobacterium tu-
berculosis DNA by the polymerase chain reaction (PCR)
technique was performed in the pathology departement.
Amplification of Mycobacterium Tuberculosis DNA by PCR
Crude DNA was first extracted from the paraffin-embed-
ded biopsy as previously described (17). A nested PCR was
then performed on 10 mL of extracted DNA. We used a pair
of primers derived from the sequence of the insertion ele-
ment IS6110, which is specific for M. Tuberculosis, and situ-
ated outside of the primers proposed by Savic et al. (18).
These primers were used in a first ampliflication step, giving
an amplified DNA fragment of 559 bp (19). A second am-
plification was then performed on an aliquot of the first
amplification product by using primers described by Savic et
al. (18), delimiting a DNA fragment of 263 bp within the
originally amplified DNA sequence. The first amplification
was carried out using PCR Master (Boehringer Mannheim,
Mannheim, Germany) in a final volume of 50 mL containing
20 pmol of each sense IS1A and antisense IS2A oligonucle-
otide primer. After initial denaturation of the DNA sample
for 3 min at 94 C, the reaction was run for 40 cycles consisting
of 30 sec at 94 C for denaturation, 2 min at 60 C for annealing,
and 2 min at 72 C for extension. The second amplification was
performed on 1 mL of the originally amplified DNA using the
primers and PCR conditions (initial denaturation of the DNA
for 13 min at 98 C followed by 40 cycles consisting of 1 min
at 92 C for denaturation, 1 min at 72 C for annealing/exten-
sion) described by Savic et al. (18). The amplified product was
FIG. 3 Hematoxylin-eosin stained sec-
tion demonstrating a granulomatous
inflammation with epitheloid cells and
a central multinucleated giant cell
(magnification, 3200).
FIG. 4 Agarose gel analysis of polymerase chain reaction (PCR) prod-
ucts visualized by ultraviolet light after ethidium-bromide staining.
Amplified M tuberculosis DNA was detected by PCR at the expected
size (263 bp) in the DNA solution obtained from sections of the biopsy
specimens (lanes e and f). Primers amplifying a 370 bp fragment in
a human genomic sequence were also used to rule out inability to
amplify DNA (lane d). H2O and DNA from an empty paraffin block
were used as negative controls (lanes b and c). DNA from a M tuber-
culosis strain was used as positive control (lane a). Lane MW con-
tained DNA molecular weight standards.
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then electrophoresed on 2% agarose gel in Tris-Acetate-
EDTA (TAE) buffer after staining with ethidium bromide. As
shown in Fig. 4, the biopsy specimen of our patient was
positive for M. tuberculosis DNA.
Follow-up
Antituberculosis therapy was maintained for a total of 9
months.
Clinical course
Five-year follow-up shows no signs of reappearance of the
inflammatory syndrome. The patient presents no complaints
under hormonal replacement therapy. Pituitary MRI shows
an empty sella with no sign of tumor reappearance.
Discussion
Before the discovery of antituberculosis drug therapy, tu-
berculomas represented as much as 30% of the intracranial
tumors in adults and 50% in children (20). The frequency is
now between 0.25% and 4% in western countries (21). A
unique localization in the pituitary is very rare, as meninges
are also usually involved. These cases present mainly as a
secondary complication of a known tuberculosis or at least
as the first manifestation of an easily diagnosed tuberculosis,
with a more-or-less obvious entry point.
Moreover, the imaging findings of pituitary tuberculomas
are nonspecific and may resemble other pituitary granulo-
mas caused by a specific lesion such as syphilis, sarcoidosis,
Langerhans cell histiocytosis, Wegener’s granulomatosis,
and even macroadenoma or lymphocytic hypophysitis.
The diagnostic puzzle presented by our patient was as-
sociated with the unique pituitary localization, with no ob-
vious primary infection site, until the finding of a granulo-
matous inflammation in the nasal cavities. The normal skin
test and sterile body fluid cultures were other factors that
made the diagnosis of tuberculosis less likely. The patho-
logical examination, while not excluding a mycobacterial
infection, was more in favor of a noninfectious granuloma-
tous lesion. This diagnosis was reinforced by the clinical
presentation and the complementary examinations, and led
finally to corticoid therapy.
Fortunately, this treatment was not associated with any
dramatic complication except for the growth of the pituitary
tumor.The early and transient improvement in the com-
plaints presented by the patient was probably related to the
antiinflammatory effect of the corticoids.
The pathological examination of the pituitary tissue ob-
tained by transsphenoidal surgery did not help in refining
the diagnosis, but confirmed the inflammatory nature of this
tumor. The antituberculosis therapy was mainly motivated
by clinical suspicion and the ineffectiveness of the corticoids.
Moreover, a mycobacterial infection was never entirely ex-
cluded in any part of the history of the patient.
PCR examination was not performed earlier in the history
of the patient because it was, at that time, a new technique
whose usefulness was just being evaluated. The patient un-
derwent a 9-month, 3-drug therapy, and the treatment was
then discontinuated. We now have a 5-yr follow-up, with no
sign of recurrence of the tumor or of the clinical complaints.
The patient is under a life-long hormonal replacement
therapy.
The intranasal cavities are probably the site of the primary
infection as no other entry points were found during the
routine follow-up. It is not clear whether the mycobacterial
infection of the pituitary resulted from a regional extension
or from a hematogenous contamination from the cavum. A
secondary extension of purulent bacterial infections has al-
ready been described from preexisting peritonsillar abcesses
(22).
In conclusion, this case report illustrates the diagnosis
difficulty of nonadenomatous pituitary lesions. An accurate
diagnosis is important, however, because it allows the ad-
ministration of an efficient medical treatment in some cases.
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